Even after a successful renal transplantation, the renal transplant recipients (RTRs) keeps on suffering the consequences of the uremic sickness. Cardiovascular risk, work capacity, and quality of life do not improve according to expectations since biological and psychological problems are not completely solved by pharmacological treatment.
Read more in the World Journal of Transplantation here.
Infusion Improves Post-Kidney Transplant Renal Function
For recipients of kidney transplant who received an infusion of dexmedetomidine, early postoperative renal function was improved, according to a study published in Annals of Medicine. However, total vessel density was not greatly different between the intervention and control groups. Yu-Change Yeh, MD, PhD, and colleagues randomly assigned transplant recipients to a control group or dexmedetomidine group. Read more in Physician’s Weekly.